Bank of Montreal’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Bank of Montreal’s Portfolio TLOG Stock Details TLOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,000	Closed	-$2K	–	4555
2015 Q4	$2K	Hold	1,000	–	–	﹤0.01%	4035
2015 Q3	$2K	Hold	1,000	–	–	﹤0.01%	3839
2015 Q2	$2K	Hold	1,000	–	–	﹤0.01%	3803
2015 Q1	$4K	Buy	+1,000	New	+$5.02K	﹤0.01%	3694
2014 Q3	–	Sell	-90	Closed	-$1K	–	4731
2014 Q2	$1K	Buy	+90	New	+$511	﹤0.01%	4616

Other funds holding TLOG

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geneva Advisors Chicago, Illinois $5.81B AUM 23.71% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Bank of Montreal's TLOG Position: Q1 2016 in Review

Bank of Montreal sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q1 2016, closing a stake of 1,000 shares — an estimated $2K sold.

Bank of Montreal first reported a position in TLOG in Q2 2014 and held it in 5 quarters. The position peaked at $4K in Q1 2015. 25 funds tracked by Wall St. Rank hold TLOG as of Q1 2016.

Bank of Montreal reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q1 2016 after selling out during the quarter.
Bank of Montreal sold 1,000 TetraLogic Pharmaceuticals Corporation shares in Q1 2016, an estimated $2K.
Bank of Montreal first reported a position in TetraLogic Pharmaceuticals Corporation in Q2 2014 and held it in 5 quarters.
Bank of Montreal's TetraLogic Pharmaceuticals Corporation position peaked at $4K in Q1 2015.
25 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q1 2016.

Based on Bank of Montreal's 13F filing for Q1 2016, filed 29 Apr 2016.